Healthcare venture capital is still breathing and soon may be off the oxygen tank.
The sector closed out 2011 in strong fashion and posted a five-quarter high in funding and recording “solid” deal activity, according to the latest quarterly report from venture capital database CB Insights.
Of course, one quarter does not a trend make. Nonetheless, the strong fourth-quarter performance is welcome news for healthcare investors and entrepreneurs feeling beleaguered by a weak IPO market, regulatory uncertainty and a future of declining reimbursements from payers and providers. In the fourth quarter of 2011, healthcare VCs invested $1.9 billion in a total of 172 deals, according to CB Insights.
To read the full, original article click on this link: Rumors of healthcare venture capital’s death have been greatly exaggerated
